Cardiff Oncology Inc (CRDF)
Healthcare
Biotechnology
0.93 $
+9.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Cardiff Oncology Inc (CRDF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.1 | -8.0 | -7.1 | -7.7 | -9.2 | -10 | -10 | -13 | -8.3 | -11 | -6.0 | -12 | -37 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.5 | 0.2 | 0.2 | 1.2 | |
| 1.6 | 1.0 | 0.9 | 1.1 | 1.2 | 1.3 | 1.2 | 1.4 | 1.7 | 1.4 | 1.3 | 1.7 | 6.0 | |
| 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.6 | 1.0 | 1.4 | 1.2 | 1.4 | 0.2 | 0.4 | -0.8 | 4.0 | -1.2 | -0.1 | -1.7 | 1.0 | |
| 0.3 | 0.3 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 11 | 3.8 | 14 | 4.6 | 14 | -9.4 | 4.5 | -15 | -5.0 | 10 | 11 | 3.3 | 19 | |
| 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.1 | 2.1 | 7.4 | 44 | 0.0 | 0.0 | 0.0 | 2.6 | 0.1 | 2.7 | |
| 4.4 | -4.1 | 6.4 | -3.0 | 6.8 | -12 | 38 | -27 | -13 | -0.6 | 7.3 | -8.9 | -16 | |
| -7.4 | -8.3 | -7.1 | -7.8 | -9.2 | -10 | -10 | -13 | -8.4 | -11 | -6.0 | -12 | -37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.